Reboxetine

Reboxetine is an antidepressant medication that belongs to a class of drugs known as selective norepinephrine reuptake inhibitors (SNRIs). It is used to treat depression and other mental health conditions such as attention deficit hyperactivity disorder (ADHD) and panic disorder. It works by restoring the balance of certain natural chemicals, or neurotransmitters, in the brain, such as norepinephrine. Reboxetine is usually taken once a day and can be taken with or without food. Common side effects include nausea, insomnia, and dry mouth.

Reboxetine, also known by the brand name Edronax (no longer available in some countries), is a medication that was previously used to treat depression in adults. However, its use has declined due to the availability of other antidepressants with potentially better side effect profiles. Here's a closer look at Reboxetine:

What it was used for:

  • Reboxetine belonged to a class of antidepressants called selective norepinephrine reuptake inhibitors (SNRIs) [1, 2].
  • It worked by blocking the reuptake of norepinephrine, a chemical messenger in the brain involved in mood regulation [1, 2]. By increasing norepinephrine levels, Reboxetine aimed to improve symptoms of depression like sadness, loss of interest, and fatigue [1].

Why it's less commonly used:

  • While Reboxetine can be effective for some people with depression, it can cause side effects like dry mouth, constipation, insomnia, and sexual dysfunction [2, 3].
  • Newer SNRIs and other classes of antidepressants like selective serotonin reuptake inhibitors (SSRIs) may offer similar benefits with a potentially lower risk of side effects [2, 3].
  • Reboxetine is no longer commercially available in some countries due to these factors [3].

Important Considerations:

  • If you were previously prescribed Reboxetine and are concerned about its use, talk to your doctor. They can discuss alternative treatment options for depression based on your individual needs and medical history.
  • Self-treating with Reboxetine or any other medication is not recommended and can be dangerous.
Anatomical Therapeutic Chemical Classification
N - Nervous system
N06 Psychoanaleptics
N06A - Antidepressants
N06AX Other antidepressants
External Links